US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

108.43

-3.3047-2.96%

Volume:7K

Turnover:731.00K

Market Cap:91.08M

PE:- -

High:110.00

Open:110.00

Low:107.04

Close:111.73

52wk High:126.40

52wk Low:55.34

Shares:840.00K

Float Shares:840.00K

Volume Ratio:0.46

T/O Rate:0.80%

Dividend:0.33

Dividend Rate:0.30%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live

Gilead announces agreement with PAHO for lenacapavir access

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS

Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call

THOMSON REUTERS

Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call

THOMSON REUTERS

Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17

Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

Amgen to deploy Veeva Vault CRM globally

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BIB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"ProShares Ultra Nasdaq Biotechnology","latestPrice":108.43,"timestamp":1789502400000,"preClose":111.7347,"halted":0,"volume":6749,"delay":0,"changeRate":-0.02957630888166341,"floatShares":840000,"shares":840000,"eps":0,"marketStatus":"Pre-Mkt","change":-3.3047,"latestTime":"09-16 05:42:50 EDT","open":110,"high":110,"low":107.035,"amount":731000.293114,"amplitude":0.026536,"askPrice":113.27,"askSize":132,"bidPrice":105.06,"bidSize":5,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":108.43,"sharesOutstanding":1040000,"nav":111.7314,"aum":93854376,"dividendRate":0.003,"bidAskSpread":0.002339,"postHourTrading":{"tag":"盘后","latestPrice":108.43,"preClose":108.43,"latestTime":"19:30 EDT","volume":12,"amount":1301.16,"timestamp":1789515007137,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.46035579120842685,"impliedVol":0.491,"impliedVolPercentile":0.784},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.46035579120842685,"shares":840000,"dividePrice":0.3253,"high":110,"amplitude":0.026536,"preClose":111.7347,"low":107.035,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":108.43,"committee":-0.927007,"eps":0,"divideRate":0.003,"volume":6749,"delay":0,"ttmEps":0,"open":110,"prevYearClose":79.7794,"prevWeekClose":109.7741,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":115.08,"twentyDayClose":109.8842,"sixtyDayClose":85.0227},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667832674","title":"Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832674?lang=en_us&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530442,"startTime":"0","endTime":"0","summary":"Rohto starts Phase II trial of RE-01 cell therapy for refractory ischemic leg ulcersRohto began CDMO manufacturing for RE-01 cell therapy used in a Phase II investigator-led trial for refractory ische","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDLJMrSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","LU1839511570.USD","BMED","LU2089984988.USD","BK4568","LU0114720955.EUR","LU0861579265.USD","LU1057294990.SGD","LU0289739699.SGD","IE00BKVL7J92.USD","IBB","LU0965509283.SGD","LU1934455277.USD","LU0058720904.USD","LU1778281490.HKD","LU2468319806.SGD","LU2357627491.SGD","TBXU","LU0889565916.HKD","LU1430594728.SGD","MEDI","BK4532","BIB","LU1585245621.USD","BK4583","LU0234570918.USD","LU1674673691.USD","LU1934455863.HKD","LU1066051498.USD","LU1037948897.HKD","BK4578","LU2112291526.USD","SG9999015945.SGD","LU1066053197.SGD","LU1061106388.HKD","LU1037948541.HKD","IE00B7SZLL34.SGD","LU2087621335.USD","IBBQ","IE00BZ1G4Q59.USD","LU0122379950.USD","LU0823416689.USD","SG9999015978.USD","TMED","LU0320765992.SGD","GILD","LU0965509010.AUD","SG9999015986.USD","BK4550","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624218","title":"Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624218","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624218?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:25","pubTimestamp":1789503924,"startTime":"0","endTime":"0","summary":"UPDATE 1-Bristol Myers sues Amgen over proposed Opdivo biosimilarSept 15 (Reuters)-Bristol Myers SquibbBMY.Nand Ono Pharmaceutical4528.Thave sued AmgenAMGN.Oin Delaware federal court, seeking to block","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N457192:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","LU0225284248.USD","LU0237698245.USD","LU0096364046.USD","BK4566","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1023059063.AUD","LU2125154935.USD","LU1670711040.USD","FTXH","LU1236620750.USD","LU2242646821.SGD","LU1868836591.USD","LU1261432733.SGD","TBXU","LU0432979614.USD","PBE","LU1291159041.SGD","LU1585245621.USD","LU1718418525.SGD","LU0306806265.USD","LU0882574055.USD","IE00B2B36J28.USD","BBH","BK4533","IE00BFXG1179.USD","04332","LU0321505868.SGD","LU2468319806.SGD","BK4139","LU2089984988.USD","AMGN","LU0061475181.USD","LU1057294990.SGD","LU1868836914.USD","LU1032466523.USD","LU1061106388.HKD","LU0985481810.HKD","LU2125154778.USD","LU2112291526.USD","IBBQ","BK4599","LU1236620834.HKD","IHE","LU0109394709.USD","BK4588","LU2133065610.SGD","LU2360032135.SGD","LU0306807586.USD","LU0321505439.SGD","LU0868494617.USD","BK4585","LU1670711123.USD","IE00B4R5TH58.HKD","IE0009355771.USD","LU1868837136.USD","BK4007","LU1074936037.SGD","LU2242652126.USD","LU1989771016.USD","LU1983299246.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","BK4559","LU1430594728.SGD","LU2596442595.SGD","LU0058720904.USD","BK4581","SG9999001440.SGD","BIB","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU0889565916.HKD","LU1323610961.USD","BK4534","LU0225771236.USD","IE0002141913.USD","LU1868836757.USD","BMY","LU1571399168.USD","LU0267386448.USD","LU0122379950.USD","LU1670710588.SGD","LU1093756325.SGD","LU1883839398.USD","LU0456855351.SGD","BK4532","IBB","LU1868837300.USD","LU0289739699.SGD","LU1093756168.USD","LU1670710661.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667490625","title":"Gilead Sciences Expands Lenacapavir Access to 14 Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2667490625","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667490625?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:43","pubTimestamp":1789487029,"startTime":"0","endTime":"0","summary":"Gilead Sciences  said Tuesday it entered into an agreement with the Pan American Health Organization to expand access to twice-yearly lenacapavir as pre-exposure prophylaxis for HIV prevention.The agreement creates a new access pathway for 14 PAHO member states in Latin America and the Caribbean outside existing voluntary licensing agreements, complementing generic access efforts across the region, the company said.The countries are Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Mexico, Panama, Paraguay, Peru, Uruguay and Venezuela, Gilead said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0965508806.USD","BK4550","LU0882574055.USD","BK4568","LU0320765992.SGD","SG9999015986.USD","BBH","IBB","BK4566","MEDI","LU0965509283.SGD","LU1037948541.HKD","IE00B3T34201.USD","LU0109394709.USD","LU2112291526.USD","TMED","LU2324357040.USD","BIB","LU1037948897.HKD","LU0965509010.AUD","LU1061106388.HKD","LU0861579265.USD","BK4588","GILD","LU1778281490.HKD","LU1571399168.USD","LU0058720904.USD","SG9999015952.SGD","LU0114720955.EUR","LU1934455277.USD","LU1934455863.HKD","LU1023059063.AUD","LU1674673691.USD","BK4585","IE0002270589.USD","TBXU","LU1430594728.SGD","LU0823416689.USD","IE00B19Z3581.USD","LU1839511570.USD","LU0234570918.USD","IE00B19Z3B42.SGD","LU1674673428.USD","IE00BKVL7J92.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","BMED","IBBQ","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667625575","title":"Gilead announces agreement with PAHO for lenacapavir access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667625575","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667625575?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485318,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced a new agreement with the Pan American Health Organization, or PAHO, to accelerate access to twice-yearly lenacapav...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1778281490.HKD","BK4550","IE00B3T34201.USD","LU1430594728.SGD","BBH","BK4588","LU1571399168.USD","IBBQ","LU0965509283.SGD","LU1585245621.USD","MEDI","LU2089984988.USD","BK4578","SG9999015986.USD","LU1066051498.USD","LU1839511570.USD","BK4583","LU2324357040.USD","LU1674673428.USD","LU0859254822.USD","LU0882574055.USD","LU0965509010.AUD","LU1061106388.HKD","LU2468319806.SGD","BK4532","LU0965509101.SGD","BMED","LU1037948541.HKD","IBB","LU1674673691.USD","BK4585","TBXU","LU0861579265.USD","LU0234570918.USD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU1037948897.HKD","BK4568","LU1066053197.SGD","LU1934455863.HKD","SG9999015952.SGD","LU1023059063.AUD","BIB","IE0002270589.USD","LU0289739699.SGD","TMED","LU0058720904.USD","SG9999015945.SGD","GILD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623063","title":"Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623063","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623063?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0965509010.AUD","LU1934455277.USD","LU2089984988.USD","BBH","LU0882574055.USD","IE00B3T34201.USD","LU0058720904.USD","LU2468319806.SGD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU0823416689.USD","SG9999015945.SGD","LU0109394709.USD","LU1037948541.HKD","LU1066053197.SGD","LU0234570918.USD","LU1057294990.SGD","TBXU","BMED","BK4583","LU1430594728.SGD","IBBQ","LU1778281490.HKD","LU1674673691.USD","IE00BSNM7G36.USD","GILD","IE00B19Z3581.USD","IE0002270589.USD","BK4532","IBB","SG9999015978.USD","BIB","BK4578","SG9999015986.USD","LU1061106388.HKD","MEDI","LU2324357040.USD","TMED","LU1571399168.USD","LU0965509283.SGD","SG9999015952.SGD","LU0859254822.USD","LU1839511570.USD","LU0861579265.USD","IE00BKVL7J92.USD","LU2357627491.SGD","BK4566","IE00B7SZLL34.SGD","LU1037948897.HKD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623061","title":"Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623061","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623061?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015986.USD","LU0965509283.SGD","LU1061106388.HKD","LU1778281490.HKD","LU0109394709.USD","LU1934455277.USD","BK4568","LU1934455194.USD","LU1057294990.SGD","SG9999015952.SGD","LU0289739699.SGD","IE00B3T34201.USD","LU2468319806.SGD","IE00BSNM7G36.USD","IBBQ","LU0122379950.USD","LU1571399168.USD","BK4532","SG9999015945.SGD","IE0002270589.USD","LU1037948541.HKD","BK4578","LU0965508806.USD","BK4550","BK4588","LU2089984988.USD","TBXU","IBB","TMED","BMED","BK4566","LU1066051498.USD","IE00B7SZLL34.SGD","BBH","IE00BZ1G4Q59.USD","BK4585","LU0859254822.USD","BIB","LU2357627491.SGD","MEDI","LU0058720904.USD","LU0965509101.SGD","LU1037948897.HKD","LU1066053197.SGD","BK4139","IE00BKVL7J92.USD","LU0965509010.AUD","LU2324357040.USD","GILD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667237756","title":"Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2667237756","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667237756?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","LU1057294990.SGD","LU0058720904.USD","LU1778281490.HKD","LU1674673691.USD","LU1037948541.HKD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1934455194.USD","LU1585245621.USD","BK4550","TBXU","LU2468319806.SGD","SG9999015978.USD","BK4585","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4583","LU0109394709.USD","LU2357627491.SGD","LU0965509101.SGD","LU0320765992.SGD","BMED","SG9999015952.SGD","LU1674673428.USD","BK4588","GILD","TMED","LU0965508806.USD","IE0002270589.USD","MEDI","BIB","LU1061106388.HKD","IBBQ","BBH","BK4566","LU0861579265.USD","LU1839511570.USD","LU1934455277.USD","BK4568","BK4578","IBB","SG9999015986.USD","LU0965509283.SGD","BK4532","LU2089984988.USD","SG9999015945.SGD","LU0859254822.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230916","title":"Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230916?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":"Gilead, PAHO agree on HIV prevention drug access in Latin America, CaribbeanSept 15 (Reuters)-U.S. drugmaker Gilead SciencesGILD.Osaid on Tuesday it had reached an agreement with the Pan American Heal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","IE0002270589.USD","LU0289739699.SGD","LU1778281490.HKD","IE00B19Z3581.USD","LU0823416689.USD","GILD","LU1066053197.SGD","LU1037948897.HKD","BK4578","SG9999015945.SGD","BK4566","LU1023059063.AUD","SG9999015986.USD","LU1934455863.HKD","SG9999015978.USD","TBXU","LU0122379950.USD","LU0320765992.SGD","LU1037948541.HKD","IBBQ","MEDI","IE00BKVL7J92.USD","BBH","LU2089984988.USD","LU1571399168.USD","LU1674673428.USD","BIB","IE00B7SZLL34.SGD","LU1061106388.HKD","LU0109394709.USD","LU2357627491.SGD","TMED","IE00BZ1G4Q59.USD","BK4139","LU0965509010.AUD","LU1430594728.SGD","BMED","LU1839511570.USD","LU1674673691.USD","LU0889565916.HKD","LU2324357040.USD","BK4568","LU0114720955.EUR","BK4585","LU0234570918.USD","LU2112291526.USD","BK4532","BK4583","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230686","title":"Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230686","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230686?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GILD","LU1585245621.USD","LU0859254822.USD","LU2089984988.USD","IE00B7SZLL34.SGD","LU1674673428.USD","BK4550","LU0965509283.SGD","BK4585","SG9999015952.SGD","LU1430594728.SGD","LU1066053197.SGD","LU1839511570.USD","IE00B3T34201.USD","LU0234570918.USD","LU1674673691.USD","LU1023059063.AUD","LU1061106388.HKD","IBBQ","LU1037948541.HKD","LU0289739699.SGD","TBXU","LU1934455863.HKD","MEDI","LU0882574055.USD","LU0861579265.USD","LU1066051498.USD","SG9999015986.USD","BK4568","TMED","BMED","LU1037948897.HKD","BK4578","IBB","BBH","SG9999015945.SGD","BK4583","BK4588","LU0058720904.USD","BK4532","BIB","LU1571399168.USD","LU0114720955.EUR","LU0965509101.SGD","LU0965509010.AUD","LU2324357040.USD","LU1778281490.HKD","BK4566","LU2468319806.SGD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623244","title":"Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623244?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:04","pubTimestamp":1789484692,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z3B42.SGD","LU1934455277.USD","BK4588","SG9999015952.SGD","LU0965509101.SGD","LU1066053197.SGD","LU2324357040.USD","SG9999015978.USD","BK4568","LU1037948897.HKD","LU0114720955.EUR","LU0058720904.USD","IE00B7SZLL34.SGD","IBBQ","BMED","LU1934455863.HKD","LU0289739699.SGD","LU0889565916.HKD","LU1061106388.HKD","BK4550","GILD","LU1037948541.HKD","IE0002270589.USD","LU1674673428.USD","LU1674673691.USD","LU0859254822.USD","LU1839511570.USD","BK4532","LU1057294990.SGD","LU2112291526.USD","LU0234570918.USD","LU1430594728.SGD","IE00B19Z3581.USD","BK4566","TMED","MEDI","BBH","LU1585245621.USD","LU0122379950.USD","TBXU","SG9999015945.SGD","BIB","LU1066051498.USD","BK4139","IBB","LU0882574055.USD","LU0965509283.SGD","LU0320765992.SGD","LU0965509010.AUD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462372","title":"Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462372?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:04","pubTimestamp":1789484692,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","SG9999015978.USD","LU0859254822.USD","BK4568","IE00B3T34201.USD","LU2324357040.USD","BK4550","LU0289739699.SGD","BMED","LU0114720955.EUR","IBB","IE00B19Z3B42.SGD","LU0882574055.USD","LU0965509010.AUD","IE00BSNM7G36.USD","BK4578","BBH","GILD","MEDI","BIB","IE00B19Z3581.USD","LU0058720904.USD","LU1934455194.USD","IBBQ","BK4139","IE00BZ1G4Q59.USD","LU0965509101.SGD","TMED","LU1061106388.HKD","LU1430594728.SGD","LU0965508806.USD","LU2089984988.USD","LU1037948541.HKD","SG9999015945.SGD","BK4532","LU1023059063.AUD","LU1934455277.USD","LU2357627491.SGD","LU1674673428.USD","LU0889565916.HKD","LU1571399168.USD","LU2112291526.USD","LU0109394709.USD","LU0234570918.USD","LU1934455863.HKD","TBXU","LU1585245621.USD","LU1674673691.USD","LU0122379950.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642502","title":"Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642502","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642502?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:17","pubTimestamp":1789474653,"startTime":"0","endTime":"0","summary":"Amgen announces dividend of R$ 0.31 per unit, payable Sept. 17Amgen declared a Q3 2026 dividend of R$ 0.31 per unit on ISIN BRAMGNBDR004.Shares trade ex-dividend from Aug. 20, 2026; last day with enti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nNDL9rWH4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","PBE","LU0109394709.USD","LU1057294990.SGD","LU0122379950.USD","LU2242646821.SGD","LU2089984988.USD","SG9999001440.SGD","LU1983299246.USD","BK4581","IE0009355771.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU0289739699.SGD","IE00BJJMRZ35.SGD","BK4585","LU2242652126.USD","TBXU","LU2112291526.USD","IBB","LU0320765992.SGD","LU1571399168.USD","PJP","IE00BJT1NW94.SGD","BK4139","IE00B4R5TH58.HKD","BK4533","BK4566","BK4599","BK4534","IBBQ","LU2468319806.SGD","LU0868494617.USD","BIB","BBH","AMGN","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1023059063.AUD","BK4588","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644589","title":"Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644589?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:36","pubTimestamp":1789472175,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX, a prescription non-opioid medici...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-partners-with-lindsey-vonn-for-journavx-awareness-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-partners-with-lindsey-vonn-for-journavx-awareness-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","BBH","IE00BJT1NW94.SGD","BK4533","PBE","LU1674673691.USD","IBBQ","LU2362541273.HKD","BK4567","IDNA","LU2362541513.USD","LU1035775433.USD","IE00B19Z9P08.USD","LU0256863811.USD","LU0757428866.USD","BK4588","SG9999001176.SGD","LU1674673428.USD","LU2456880835.USD","VERX","BK4023","IE0002141913.USD","LU1069344957.HKD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","TBXU","IE00B19Z9Z06.USD","LU2362540622.SGD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU1559883803.SGD","SG9999001176.USD","IE00BFTCPJ56.SGD","BIB","BK4532","BK4585","IBB","LU0061475181.USD","LU1585245621.USD","LU2237438978.USD","LU0566484027.USD","GNMX","LU1093756325.SGD","LU0109394709.USD","IE00B2B36J28.USD","IE0009355771.USD","LU0234570918.USD","VRTX","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641173","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641173?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:20","pubTimestamp":1789471221,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Centene (CNC), Natera (NTRA) and Vertex Pharmaceut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","LU0053671581.USD","BK4585","LU1035775433.USD","XLV","NTRA","LU0859254822.USD","CNC","LU0130518102.USD","GNMX","IBBQ","LU1291159041.SGD","HCSG","IE0002270589.USD","LU1988902786.USD","PBE","BK4023","LU0289739699.SGD","CNCG","LU0648000940.SGD","LU0823416689.USD","LU2065171311.SGD","TBXU","VRTX","BK4567","LABU","BK4139","IE0009355771.USD","IE00B19Z3581.USD","LU2236285917.USD","LU2462157665.USD","HELX","VERX","BK4137","LU1430594728.SGD","XBI","BK4581","IBB","IE00B19Z9Z06.USD","BIB","LU0234570918.USD","GNOM","LU1674673691.USD","LU0128526141.USD","BBH","LU0012050646.USD","LU2456880835.USD","LU1585245621.USD","LU2065169927.USD","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641127","title":"Amgen to deploy Veeva Vault CRM globally","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641127?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:10","pubTimestamp":1789470620,"startTime":"0","endTime":"0","summary":"Veeva Systems (VEEV) announced that Amgen (AMGN) plans to deploy Veeva Vault CRM globally, building on a collaboration spanning more than a decade....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-to-deploy-veeva-vault-crm-globally-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-to-deploy-veeva-vault-crm-globally-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4534","LU2468319806.SGD","BK4504","BIB","BK4588","LU2089984988.USD","BK4599","LU0122379950.USD","LU0006306889.USD","BK4585","BK4566","LU2242652126.USD","IBBQ","04332","AMGN","IE0009355771.USD","BK4167","PBE","SG9999001440.SGD","LU0106261372.USD","LU0170899867.USD","LU1983299246.USD","BK4533","LU0109394709.USD","LU2112291526.USD","LU0320765992.SGD","LGHT","IE00B4R5TH58.HKD","IBB","LU1989764664.SGD","IE00B2B36J28.USD","LU1989764748.USD","LU0868494617.USD","LU1057294990.SGD","LU0058720904.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","TBXU","LU0266013472.USD","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU0289739699.SGD","BK4139","BK4613","VEEV","LU0889565916.HKD","LU1023059063.AUD","LU1571399168.USD","IE0002141913.USD","BK4528","BBH","PJP","LU2242646821.SGD","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667109456","title":"Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667109456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667109456?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:33","pubTimestamp":1789461180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.0% to 5.42 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.81, which the company achieved Sept. 16.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.9% and Amgen Inc. remained unchanged.Trading volume totaled 59.4 million shares, compared to the 50-day average of 95.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","BIB","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2242646821.SGD","BBH","IE00BZ08YR35.GBP","LU0058720904.USD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0109394709.USD","LU1023059063.AUD","BK4585","IE0009355771.USD","BK4566","BK4534","IE00B2B36J28.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0889565916.HKD","LU1061106388.HKD","BK1515","LU1983299246.USD","LU2112291526.USD","TBXU","HK0000165453.HKD","LU0868494617.USD","BK4139","LU1057294990.SGD","01177","IE00BZ08YT58.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK1191","BK1521","IE0002141913.USD","BK4533","PBE","PJP","AMGN","BK4581","LU2242652126.USD","LU1571399168.USD","BK4599","BK4588","LU0320765992.SGD","IBBQ","IBB","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695453","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695453?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:36","pubTimestamp":1789418160,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.87% to $146.41 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Gilead Sciences Inc. closed 6.92% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and Abbott Laboratories  rose 1.12% to $103.09.Trading volume  remained 1.5 million below its 50-day average volume of 6.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU1066053197.SGD","IE00B19Z3581.USD","LU0861579265.USD","LU1571399168.USD","LU1674673691.USD","SG9999015952.SGD","LU1430594728.SGD","IE00B7SZLL34.SGD","MEDI","IE00BSNM7G36.USD","LU1839511570.USD","IBBQ","TMED","LU1778281490.HKD","BK4583","IE00B19Z3B42.SGD","BBH","LU2468319806.SGD","TBXU","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU1061106388.HKD","LU1066051498.USD","LU0320765992.SGD","IBB","LU1037948541.HKD","BK4578","LU2112291526.USD","LU0058720904.USD","SG9999015978.USD","IE00BKVL7J92.USD","BK4566","BMED","LU0965508806.USD","LU0965509283.SGD","LU1023059063.AUD","LU1585245621.USD","LU1934455194.USD","LU0114720955.EUR","BIB","LU0859254822.USD","LU0889565916.HKD","LU0882574055.USD","BK4585","LU0965509010.AUD","BK4550","LU2089984988.USD","LU0122379950.USD","BK4139","BK4568","IE00B3T34201.USD","LU0109394709.USD","LU0234570918.USD","SG9999015986.USD","LU2357627491.SGD","LU1934455277.USD","LU1037948897.HKD","LU0289739699.SGD","LU2087621335.USD","LU1934455863.HKD","BK4532","LU2324357040.USD","LU0823416689.USD","IE0002270589.USD","GILD","SG9999015945.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695950","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695950?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:35","pubTimestamp":1789418100,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  advanced 1.10% to $381.50 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Amgen Inc. closed 14.66% below its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and AbbVie Inc.  rose 1.81% to $261.77.Trading volume  eclipsed its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","SG9999001440.SGD","IE0002141913.USD","BK4139","BK4585","LU2468319806.SGD","IBB","04332","LU2089984988.USD","IE00BJT1NW94.SGD","TBXU","BK4581","LU0868494617.USD","IE00BFTCPJ56.SGD","PJP","BK4566","BK4588","IE00B4R5TH58.HKD","BK4599","BBH","LU1057294990.SGD","LU2242652126.USD","LU0889565916.HKD","IBBQ","LU0109394709.USD","BK4534","IE00B2B36J28.USD","PBE","LU0320765992.SGD","LU1571399168.USD","BK4533","LU1023059063.AUD","LU2112291526.USD","LU0289739699.SGD","LU2242646821.SGD","LU1983299246.USD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","AMGN","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667070","title":"Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667070","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667070?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:30","pubTimestamp":1789403411,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The phase 3 study A Phase 3 Randomized, Double-blind, Placebo-controlled Stu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","BK4211","LU2112291526.USD","LU1057294990.SGD","PJP","BK4588","SG9999001440.SGD","IBB","BK4533","LU0320765992.SGD","BBH","BK4534","LU1571399168.USD","LU1061106388.HKD","BK4566","LU0868494617.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","IE00BJJMRZ35.SGD","ISBC","IE00B2B36J28.USD","LU0289739699.SGD","BK4139","LU1983299246.USD","IE0002141913.USD","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","TBXU","AMGN","BK4585","LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","PBE","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4599","IBBQ","LU2242646821.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661729","title":"Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661729","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661729?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:04","pubTimestamp":1789394640,"startTime":"0","endTime":"0","summary":"1404 GMT - Roche Holding and GSK's Chinese partners reported strong clinical-trial data for their respective lung-cancer drug candidates in China-only clinical trials, analysts at J.P. Morgan write in a research note. Both drugs, one from GSK and partner Hansoh Pharmaceutical and another from Roche and MediLink, showed a 54% improvement in overall survival rates in the trials. This seems competitive relative to a 40% benefit shown by Amgen's Imdelltra in a global trial, the analysts say. Roche and MediLink's candidate tam-peli has a better tolerability profile than GSK and Hansoh's ris-rez, they add. Ris-rez has better median overall-survival data, but it will be important to confirm this result in a global trial, according to JPM. GSK shares rise 4.6% and Roche's jump 5.7%, while Hansoh's close 5.1% higher.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","SG9999001440.SGD","LU0868494617.USD","LU0320765992.SGD","LU1057294990.SGD","IE00B2B36J28.USD","CANC","IBBQ","LU2242652126.USD","LU2112291526.USD","HRTS","IE0002141913.USD","TBXU","03692","RHHBY","BK1589","IBB","LU2089984988.USD","BK4566","BBH","LU1983299246.USD","LU1571399168.USD","LU0109394709.USD","PBE","LU2468319806.SGD","BK4007","IE00BJJMRZ35.SGD","BK4581","AMGN","BIB","GSK","IE00B4R5TH58.HKD","BK4599","IE00BJT1NW94.SGD","LU0122379950.USD","GSKH","LU0289739699.SGD","BK4532","LU0058720904.USD","LU1061106388.HKD","BK1191","LU1829250122.USD","03165","BK4534","LU1023059063.AUD","BK4533","LU0889565916.HKD","IE0009355771.USD","GSK.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}